GENNQ — Genesis Healthcare Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $984.99m
- $3.91bn
Annual income statement for Genesis Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,732 | 5,374 | 4,977 | 4,566 | 3,906 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5,346 | 5,850 | 4,895 | 4,384 | 3,890 |
| Operating Profit | 387 | -476 | 82 | 182 | 16.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -136 | -970 | -375 | 9.23 | -107 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -118 | -1,067 | -372 | 7.47 | -103 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -64 | -579 | -235 | 14.6 | -59 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -64 | -579 | -235 | 14.6 | -59 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.281 | -3.44 | -1.42 | 0.3 | -1.01 |